As shown in Figure 1, we confirmed that SPE could block the PD-1/PD-L1 immune checkpoint pathway and improve T-cell activation, thus, we hypothesized that SPE would induce killing of cancer cells mediated by T-cell activation. The gene discussed is PDCD1; the disease is cancer.